Puma Biotechnology | PBYI - Market Capitalization


Puma Biotechnology reported $453.6M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amgen USD 195.44B 5.55B Jun/2026
Biogen USD 31.9B 5B Jun/2026
BioMarin Pharmaceutical USD 11.06B 196M Jun/2026
Exelixis USD 13.54B 2.65B Jun/2026
Gilead Sciences USD 156.86B 16.13B Jun/2026
Glaxosmithkline GBP 109.29B 9.36B Mar/2026
Incyte USD 22.65B 3.92B Jun/2026
MacroGenics USD 184M 82M Mar/2026
Novartis USD 240.59B 67.17B Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
Takeda JPY 8.2T 809.7B Jun/2026
TG Therapeutics USD 8.41B 3.1B Jun/2026
Ultragenyx Pharmaceutical USD 3.29B 1.23B Jun/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026